BodiHekang Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Investors
  • 4

BodiHekang General Information

Description

Developer of immunotherapy therapeutics designed to restore immune tolerance for autoimmune and inflammatory diseases. The company offers engineered T-cell platforms, oral immunomodulatory compounds, and immune regulation technologies with targeted tolerance reconstruction capabilities, enabling patients with chronic autoimmune disorders to access safer and more durable treatment approaches.

Contact Information

Website
www.benethera.com
Formerly Known As
Bodihekang (Beijing) Biotechnology Co., Ltd., BiodiHekang (Beijing) Biotechnology
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 5011, 5th Floor, Independent Innovation Building
  • Number 6 Chuangye Road, Shangdi Information Industry Base, Haidian District
  • Beijing, 100085
  • China
+86 138
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • Room 5011, 5th Floor, Independent Innovation Building
  • Number 6 Chuangye Road, Shangdi Information Industry Base, Haidian District
  • Beijing, 100085
  • China
+86 138

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BodiHekang Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Early Stage VC (Series A) 21-May-2026 Completed Generating Revenue
5. Accelerator/Incubator 01-Feb-2025 Completed Generating Revenue
4. Early Stage VC 23-Jan-2025 Completed Generating Revenue
3. Secondary Transaction - Private 12-Apr-2024 Completed Generating Revenue
2. Secondary Transaction - Private Completed Generating Revenue
1. Early Stage VC 19-Jan-2023 Completed Generating Revenue
To view BodiHekang’s complete valuation and funding history, request access »

BodiHekang Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Lapam Capital Venture Capital Minority
Shanghai Fudan Science Park Venture Capital Venture Capital Minority
Lotus Lake Ventures Venture Capital Minority
Beijing FOF Capital Growth/Expansion Minority
To view BodiHekang’s complete investors history, request access »

Ready to get started?

Request a free trial

BodiHekang FAQs

  • When was BodiHekang founded?

    BodiHekang was founded in 2021.

  • Where is BodiHekang headquartered?

    BodiHekang is headquartered in Beijing, China.

  • What industry is BodiHekang in?

    BodiHekang’s primary industry is Drug Discovery.

  • Is BodiHekang a private or public company?

    BodiHekang is a Private company.

  • What is BodiHekang’s current revenue?

    The current revenue for BodiHekang is .

  • Who are BodiHekang’s investors?

    Lapam Capital, Shanghai Fudan Science Park Venture Capital, Lotus Lake Ventures, and Beijing FOF Capital have invested in BodiHekang.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process